GH Research (GHRS) News Today $8.00 +0.26 (+3.36%) (As of 10/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period GH Research (NASDAQ:GHRS) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comGH Research PLC (NASDAQ:GHRS) Shares Bought by Lynx1 Capital Management LPLynx1 Capital Management LP grew its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 19.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,966,726 shares of the company's stock after purchasing an additiSeptember 27, 2024 | marketbeat.comGH Research PLC (NASDAQ:GHRS) to Post FY2024 Earnings of ($0.75) Per Share, HC Wainwright ForecastsGH Research PLC (NASDAQ:GHRS - Free Report) - Equities researchers at HC Wainwright upped their FY2024 EPS estimates for GH Research in a report issued on Thursday, September 5th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of ($0.75) for the yeSeptember 9, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and issued a $40.00 price objective on shares of GH Research in a research report on Thursday.September 5, 2024 | marketbeat.comBuy Rating Affirmed on GH Research Amid Anticipated Phase 2 Advances and Strong Market PotentialSeptember 5, 2024 | markets.businessinsider.comIrish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug TrialsSeptember 5, 2024 | msn.comMaintaining Buy Rating on GH Research Amidst CEO Transition and Promising GH001 TrialsSeptember 5, 2024 | markets.businessinsider.comBuy Rating Affirmed for GH Research Amid Anticipated Clinical Advances and Strong LeadershipSeptember 4, 2024 | markets.businessinsider.comJMP Securities Reaffirms Market Outperform Rating for GH Research (NASDAQ:GHRS)JMP Securities reiterated a "market outperform" rating and issued a $39.00 price target on shares of GH Research in a research note on Wednesday.September 4, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Issues Earnings Results, Beats Expectations By $0.03 EPSGH Research (NASDAQ:GHRS - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.20) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.03.September 4, 2024 | marketbeat.comGH Research Names Velichka Villy Valcheva CEO - Quick FactsSeptember 3, 2024 | nasdaq.comGH Research (NASDAQ:GHRS) Shares Gap Down to $10.50GH Research (NASDAQ:GHRS) Shares Gap Down to $10.50September 3, 2024 | marketbeat.comGH Research Reports Second Quarter 2024 Financial Results and Provides Business UpdatesSeptember 3, 2024 | globenewswire.comGH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive OfficerSeptember 3, 2024 | globenewswire.comGH Research (NASDAQ:GHRS) Shares Down 4% GH Research (NASDAQ:GHRS) Shares Down 4%August 26, 2024 | marketbeat.comGH Research PLC (1KA.F)August 24, 2024 | uk.finance.yahoo.comGH Research PLC (1KA.SG)August 22, 2024 | uk.finance.yahoo.comGH Research (NASDAQ:GHRS) Stock Price Up 2.6%GH Research (NASDAQ:GHRS) Stock Price Up 2.6%August 22, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Gap Up to $10.57GH Research (NASDAQ:GHRS) Shares Gap Up to $10.57August 20, 2024 | marketbeat.comEquities Analysts Offer Predictions for GH Research PLC's Q1 2025 Earnings (NASDAQ:GHRS)GH Research PLC (NASDAQ:GHRS - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of GH Research in a research report issued to clients and investors on Wednesday, July 31st. HC Wainwright analyst P. Trucchio anticipates that the company will post eaAugust 2, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Receives "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $40.00 price objective on shares of GH Research in a report on Wednesday.July 31, 2024 | marketbeat.comGHRS GH Research PLCJuly 19, 2024 | seekingalpha.comGH Research (NASDAQ:GHRS) Shares Gap Up to $11.37GH Research (NASDAQ:GHRS) Shares Gap Up to $11.37July 11, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 4.7%GH Research (NASDAQ:GHRS) Trading 4.7% HigherJuly 9, 2024 | marketbeat.com3 Psychedelic Stocks to Ride to the Moon and BeyondJuly 6, 2024 | investorplace.comGH Research (NASDAQ:GHRS) Trading Down 2.6%GH Research (NASDAQ:GHRS) Stock Price Down 2.6%July 3, 2024 | marketbeat.comGH Research PLC (NASDAQ:GHRS) Sees Large Increase in Short InterestGH Research PLC (NASDAQ:GHRS - Get Free Report) was the target of a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 1,320,000 shares, an increase of 12.8% from the May 31st total of 1,170,000 shares. Currently, 4.3% of the shares of the company are short sold. Based on an average daily volume of 73,500 shares, the short-interest ratio is currently 18.0 days.July 1, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 3.7%GH Research (NASDAQ:GHRS) Stock Price Up 3.7%June 13, 2024 | marketbeat.comGH Research PLC (NASDAQ:GHRS) Shares Acquired by BVF Inc. ILBVF Inc. IL grew its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 12.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,400,158 shares of the company's stock after buying an additionaJune 13, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading 3.3% Higher GH Research (NASDAQ:GHRS) Shares Up 3.3%June 7, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Down 6.2%GH Research (NASDAQ:GHRS) Trading Down 6.2%June 5, 2024 | marketbeat.comShort Interest in GH Research PLC (NASDAQ:GHRS) Decreases By 9.5%GH Research PLC (NASDAQ:GHRS - Get Free Report) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,340,000 shares, a drop of 9.5% from the April 30th total of 1,480,000 shares. Based on an average daily volume of 92,300 shares, the short-interest ratio is presently 14.5 days. Currently, 4.4% of the company's shares are sold short.June 3, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Sets New 1-Year High at $14.66GH Research (NASDAQ:GHRS) Reaches New 12-Month High at $14.66June 3, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 6.4%GH Research (NASDAQ:GHRS) Trading 6.4% HigherMay 31, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Down 6.3% GH Research (NASDAQ:GHRS) Stock Price Down 6.3%May 29, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 3.4%GH Research (NASDAQ:GHRS) Stock Price Down 3.4%May 17, 2024 | marketbeat.comWall Street Analysts Predict a 166.89% Upside in GH Research (GHRS): Here's What You Should KnowMay 10, 2024 | finance.yahoo.comQ2 2024 EPS Estimates for GH Research PLC Reduced by Analyst (NASDAQ:GHRS)GH Research PLC (NASDAQ:GHRS - Free Report) - Research analysts at HC Wainwright dropped their Q2 2024 earnings per share (EPS) estimates for GH Research in a research report issued on Tuesday, May 7th. HC Wainwright analyst P. Trucchio now forecasts that the company will earn ($0.22) per share fMay 10, 2024 | marketbeat.comBuy Rating Affirmed for GH Research Amid Promising Trials and Regulatory MilestonesMay 8, 2024 | markets.businessinsider.comGH Research's (GHRS) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $40.00 price objective on shares of GH Research in a research note on Tuesday.May 7, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Gap Up Following Analyst UpgradeGH Research (NASDAQ:GHRS) Shares Gap Up on Analyst UpgradeMay 6, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Price Target Increased to $31.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group upped their price objective on shares of GH Research from $30.00 to $31.00 and gave the company a "buy" rating in a report on Monday.May 6, 2024 | marketbeat.comGHRS Stock Earnings: GH Research Beats EPS for Q1 2024May 3, 2024 | investorplace.comGH Research Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 3, 2024 | globenewswire.comGH Research PLC (NASDAQ:GHRS) Sees Large Growth in Short InterestGH Research PLC (NASDAQ:GHRS - Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,450,000 shares, an increase of 10.7% from the March 31st total of 1,310,000 shares. Currently, 5.0% of the shares of the company are short sold. Based on an average daily volume of 127,200 shares, the days-to-cover ratio is currently 11.4 days.May 1, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 3.9%GH Research (NASDAQ:GHRS) Trading 3.9% HigherApril 30, 2024 | marketbeat.comMGB expands effort to make medical research more sustainableApril 26, 2024 | bizjournals.comGH Video Preview: Gregory in Trouble, Joss Tells Jason She Did Something She RegretsApril 26, 2024 | msn.comGH Research (NASDAQ:GHRS) Shares Up 6.8%GH Research (NASDAQ:GHRS) Trading 6.8% HigherApril 22, 2024 | marketbeat.comGeneral Hospital Video Preview: Is Cyrus the Key to Bringing Down Sonny?April 18, 2024 | yahoo.com Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover GHRS Media Mentions By Week GHRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GHRS News Sentiment▼0.300.70▲Average Medical News Sentiment GHRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GHRS Articles This Week▼11▲GHRS Articles Average Week Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Design Therapeutics News Atai Life Sciences News Sangamo Therapeutics News Revance Therapeutics News PMV Pharmaceuticals News Castle Biosciences News Kura Oncology News Ardelyx News Tarsus Pharmaceuticals News ARS Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GHRS) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
